Nifty Pharma - Yearly Gainers Stocks - Highest Return Stocks in the Last 1 Year

	Company Name	Sector	CMP	Price Change	Market Cap (Cr)	Current PE	Industry P/E	TTM EPS (Rs.)	Last 1 Year Gain(%)	DeciZen
1	Laurus Labs	Healthcare	1,385	-2.77%	76,956 Mid Cap	103.93	46.98	13.71	113.53%	1 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
2	Torrent Pharma	Healthcare	4,463	-0.22%	1,51,385 Large Cap	69.08	46.98	64.75	40.69%	1 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
3	Gland Pharma	Healthcare	2,268	-0.87%	37,741 Small Cap	29.04	46.98	78.78	38.82%	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
4	Glenmark Pharma	Healthcare	2,144	-2.86%	62,289 Mid Cap	0.00	46.98	-7.12	38.09%	1 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
5	JB Chem & Pharma	Healthcare	2,204	-0.28%	35,481 Small Cap	52.63	46.98	41.98	31.79%	1 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
6	Wockhardt	Healthcare	1,833	-2.87%	30,663 Small Cap	96.73	46.98	19.51	24.88%	3 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
7	Aurobindo Pharma	Healthcare	1,454	0.54%	83,208 Mid Cap	34.46	46.98	41.97	24.51%	1 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
8	Biocon	Healthcare	414	-0.53%	67,470 Mid Cap	1813.72	46.98	0.23	23.11%	2 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
9	Ipca Laboratories	Healthcare	1,634	-0.09%	41,497 Mid Cap	36.64	46.98	44.64	19.51%	1 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
10	Ajanta Pharma	Healthcare	3,073	2.01%	37,632 Mid Cap	39.75	46.98	75.78	16.00%	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
11	Zydus Lifesciences	Healthcare	1,098	-0.71%	1,11,264 Mid Cap	31.26	46.98	35.38	13.59%	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
12	Lupin	Healthcare	2,249	-0.65%	1,03,490 Mid Cap	16.26	46.98	139.24	13.53%	2 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
13	Alkem Laboratories	Healthcare	5,295	-1.07%	63,998 Mid Cap	29.29	46.98	182.76	9.81%	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
14	Sun Pharma Inds.	Healthcare	1,787	0.43%	4,26,938 Large Cap	162.74	46.98	10.93	5.02%	1 Q V+ PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
15	Divis Lab	Healthcare	6,639	-1.74%	1,79,361 Large Cap	68.80	46.98	98.20	1.97%	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
16	Mankind Pharma	Healthcare	2,372	-0.80%	98,745 Mid Cap	48.46	46.98	49.34	1.47%	1 Q V PT	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.